Marshall, Aren E. http://orcid.org/0000-0003-2803-0941
Liang, Yijing
Couse, Madeline
McConkey, Haley
Brudno, Michael
Bernier, Francois
van Karnebeek, Clara
Dyment, David A.
Innes, Micheil
Lamont, Ryan
Parboosingh, Jillian
Marshall, Deborah
Marshall, Christian
Mendoza, Roberto
Dowling, James
Hayeems, Robin
Knoppers, Bartha
Lehman, Anna
Mostafavi, Sara
Sadikovic, Bekim http://orcid.org/0000-0001-6363-0016
Boycott, Kym M.
Dyment, David A.
Kernohan, Kristin D.
,
Funding for this research was provided by:
Genome Canada (OGI‐147, OGI-188)
Ontario Genomics Institute (OGI‐147, OGI-188, OGI‐147, OGI‐147, OGI-188, OGI-188, OGI‐147, OGI‐147)
Gouvernement du Canada | Canadian Institutes of Health Research (MFE-176616, FDN‐154279)
Genome Alberta
Genome British Columbia
Canada Research Chairs
Ontario Research Fund
Article History
Received: 8 August 2023
Revised: 12 October 2023
Accepted: 16 October 2023
First Online: 31 October 2023
Competing interests
: BS is a shareholder in EpiSign Inc., a biotech company involved in commercialization of EpiSign<sup>TM</sup> technology.